Clinical Trial Update: Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immunogenicity of Fluzone High-Dose influenza vaccine in pediatric patients with cancer or HIV; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• HIV Infection

Drugs mentioned

• Fluzone High-Dose (Influenza vaccine, high-dose)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: HIV, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-09-12